FDA Alzheimer's Drug OK Opens Door To Medicare Coverage

The U.S. Food and Drug Administration handed full approval to Eisai and Biogen's Alzheimer's treatment Leqembi on Thursday following a study that verified the drug's ability to slow cognitive decline in the...